The recipient will acknowledge receipt of the drug by returning the INDRR-1 form indicating shipment content and condition. Damaged supplies will be replaced. Accurate records of all study drug dispensed from and returned to the study site should be recorded by using the institution’s drug inventory log or the NCI drug accountability log. All partially used or empty containers should be disposed of at the study site according to institutional standard operating procedure. Return 43 Protocol: 2014-0443 Version 2.1 Version Date: 11 April 2016 unopened, expired, or unused study drug with the Inventory of Returned Clinical Material form as directed by Galena Biopharma. 6.8 Disclosure of data Patient medical information obtained by this study is confidential, and disclosure to third parties other than those noted above is prohibited.